Aktie 858560 ELI LILLY AND COMPANY
Zu einer Liste hinzufügen

Verbindungen Eli Lilly and Company

Aktien

858560

US5324571083

LLY

Pharmazeutika

Markt geschlossen - Nyse
Andere Börsenplätze
 22:00:02 16.01.2026 		% 5 Tage Veränd. 1. Jan.
1.038,40 USD +0,53 % Intraday Chart für Eli Lilly and Company -2,37 % -3,38 %
16.01. Novos Wegovy-Pille startet vielversprechend im Abnehmrennen gegen Lilly RE
16.01. Novo-Nordisk-Aktie steigt nach britischer Zulassung höherer Wegovy-Dosis DJ

49

Börsennotierte Unternehmen

50

Private Unternehmen

853

Insiders

Beziehungs-Chart der börsennotierten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene börsennotierte Unternehmen: Eli Lilly and Company

ADOBE INC.
David Ricks
ARCHER-DANIELS-MIDLAND COMPANY
Juan Luciano
BECTON, DICKINSON AND COMPANY
Jeffrey Henderson
Antoine Ezell
INTERNATIONAL FLAVORS & FRAGRANCES INC.
Jon Fyrwald
LOWE'S COMPANIES, INC.
Ralph Alvarez
PROCTER & GAMBLE COMPANY
Jon Moeller
ROCHE HOLDING AG
Levi Garraway
Wafaa Mamilli
AUTOZONE, INC.
Jamere Jackson
MYRIAD GENETICS, INC.
Daniel Skovronsky
VERICEL CORPORATION
Robert Zerbe
Dominick Colangelo
INOTIV, INC.
Michael Harrington
Andrea Castetter
USBC, INC.
Larry Ellingson
James Anderson
BIOMARIN PHARMACEUTICAL INC.
Willard Dere
Barbara Bodem
MASTERCARD, INC.
Gabrielle Greene-Sulzberger
OMEROS CORPORATION
Arnold Hanish
Thomas Bumol
Catherine A. Melfi
ACUMEN PHARMACEUTICALS, INC.
Eric Siemers
Russell Barton
Amber Dilley
AMICUS THERAPEUTICS, INC.
Simon Harford
Eiry Roberts
COLLEGIUM PHARMACEUTICAL, INC.
Gino Santini
Carlos Paya
VEEVA SYSTEMS INC.
Mary Lynne Hedley
ANNEXON, INC.
Thomas Wiggans
Jamie Dananberg
Michael Overdorf
GENMAB A/S
Deirdre Connelly
Anders Gersel Pedersen
Rolf K. Hoffmann
Elizabeth O'Farrell
Paolo Augusto Paoletti
MACROGENICS, INC.
Scott Jackson
Stephen Eck
ADAMA LTD.
Jon Fyrwald
ZEALAND PHARMA A/S
David M. Kendall
Enrique Conterno
Elaine Sullivan
EMERGENT BIOSOLUTIONS INC.
Marvin White
Neal Fowler
DUKE ENERGY CORPORATION
Webster Dunbar
Robert Davis
KARYOPHARM THERAPEUTICS INC.
Lori Macomber
Stuart Poulton
VERASTEM, INC.
John Johnson
Colleen Mockbee
Brian Stuglik
TREVI THERAPEUTICS, INC.
Dominick Colangelo
Michael Heffernan
TRAVERE THERAPEUTICS, INC.
Bill Rote
Casey Logan
ASSEMBLY BIOSCIENCES, INC.
Susan Mahony
William Ringo
ZAI LAB LIMITED
Joshua Smiley
Richard Gaynor
APTEVO THERAPEUTICS INC.
Marvin White
Grady Grant
IQVIA HOLDINGS INC.
William Kaelin
WUXI BIOLOGICS (CAYMAN) INC.
Jackson Tai
Zhi Sheng Chen
ROCKET PHARMACEUTICALS, INC.
Gaurav D. Shah
Jonathan Schwartz
BEAM THERAPEUTICS INC.
Christi Shaw
Carole Ho
ELANCO ANIMAL HEALTH INCORPORATED
R. Hoover
Jeffrey Simmons
Michael Harrington
David Kinard
MODERNA, INC.
Stéphane Bancel
Shah Hussain
WEREWOLF THERAPEUTICS, INC.
Steven Bloom
Michael Sherman
PYXIS ONCOLOGY, INC.
Freda Lewis-Hall
Rachel Humphrey
AN2 THERAPEUTICS, INC.
Joseph Zakrzewski
Patricia Martin
Robin Readnour
IMMUNOVANT, INC.
Atul Pande
William L. Macias
Julia G. Butchko
Ian Gourley
ROYALTY PHARMA PLC
Carole Ho
CENTESSA PHARMACEUTICALS PLC
Mary Lynne Hedley
TRAEGER, INC.
Ralph Alvarez
FIRST WATCH RESTAURANT GROUP, INC.
Ralph Alvarez
OMNIAB, INC.
Carolyn Bertozzi
RAPPORT THERAPEUTICS, INC.
Steven Paul
David Bredt
Jeffrey Sevigny

Aktive Beziehungen

Vergangene Beziehungen

Beziehungs-Chart der privaten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene private Unternehmen: Eli Lilly and Company

ImClone LLC

Gino Santini
William Chin
Lilly Endowment, Inc.

John Lechleiter
Charles Golden
Cerecin, Inc.

Pharmaceuticals: Major

Claude H. Nash
Joseph Zakrzewski
Sorbent Therapeutics, Inc.

Pharmaceuticals: Major

Randall E. Woods
Scott Minick
Thunderbird School of Global Management

Other Consumer Services

Sharon L. Sullivan
Jacques Tapiero
CS-Keys, Inc.

Medical Specialties

Robert J. Feeney
Carrie J. L. Bates
Biotechnology Innovation Organization

Miscellaneous Commercial Services

Steven Paul
Jon Fyrwald
Edward O. Lanphier
Susan B. Washer
Jan Lundberg
James Sapirstein
Martin Babler
Charl van Zyl
Flowco, Inc.

Ronald W. Dollens
John Barnard
Millendo Therapeutics US, Inc.

Carol Gallagher
Mary Lynne Hedley
Indiana University Foundation, Inc.

Investment Trusts/Mutual Funds

Randall L. Tobias
Robert Zerbe
Patricia Martin
Duke University

Other Consumer Services

Peter Nicholas
Pierre V. Trân
William Kaelin
Harvard University

Other Consumer Services

Deirdre Connelly
Martin Feldstein
Barry I. Eisenstein
William Chin
Arsenal Capital Management LP

Investment Managers

James Rothman
T. Spencer Williamson
American Chemical Society

Miscellaneous Commercial Services

John Lechleiter
Franklyn Prendergast
Thomas Verhoeven
Homer Pearce
Butler University

Other Consumer Services

Steven Paul
Ronald W. Dollens
Brian A. Stemme
Timothy Franson
Twilight Venture Partners LLC

Investment Managers

Richard DiMarchi
Ron D. Henriksen
Jim R. Baumgardt
DePauw University

Other Consumer Services

R. Hoover
James Cornelius
Indiana University

Other Consumer Services

Richard DiMarchi
Jerome H. Fleisch
University of Indianapolis

Other Consumer Services

Lorenzo M. Tallarigo
James Cornelius
Barton Peterson
Wabash College

Other Consumer Services

Frederick W. Ruebeck
David A. Broecker
James A. Davlin
Indiana University Health Bloomington, Inc.

Hospital/Nursing Management

Anne Nobles
James A. Davlin
American Society of Clinical Oncology, Inc.

Medical/Nursing Services

Mary Lynne Hedley
Anders Gersel Pedersen
National Academy of Sciences

Miscellaneous Commercial Services

Steven Paul
William Kaelin
National Association of Manufacturers

Miscellaneous Commercial Services

Martin Feldstein
Alex Michael Azar
Pharmaceutical Research & Manufacturers of America

Biotechnology

John Lechleiter
Peter Anastasiou
Regenstrief Foundation

Ronald W. Dollens
Barton Peterson
American Academy of Arts & Sciences

Miscellaneous Commercial Services

Peter Nicholas
George Fisher
Martin Feldstein
William Kaelin
National Academy of Engineering

Miscellaneous Commercial Services

George Fisher
Mark Levin
James R. Swartz
National Association of Corporate Directors (Virginia)

Miscellaneous Commercial Services

Julia Brown
James A. Harper
Karen Horn
Project HOPE-The-People-To-People HealthFoundation, Inc.

Medical/Nursing Services

Gerhard Mayr
Robert Davis
The Business Roundtable

Miscellaneous Commercial Services

Sidney Taurel
Juan Luciano
John Lechleiter
Jon Moeller
Indianapolis Museum of Art, Inc.

Other Consumer Services

Sidney Taurel
Daniel Skovronsky
The Business Council

Miscellaneous Commercial Services

Sidney Taurel
Juan Luciano
John Lechleiter
Brock Capital Group LLC

Investment Managers

Karen Horn
Ellen Marram
The Biotechnology Institute

Miscellaneous Commercial Services

Edward O. Lanphier
Thomas Wiggans
Accelerator Services Corp

Investment Managers

Jan Lundberg
Homer Pearce
Lilly Research Laboratories

Miscellaneous Commercial Services

Thomas Verhoeven
Alpheus Bingham
Daniel Skovronsky
Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Steven Paul
Freda Lewis-Hall
Barry I. Eisenstein
Barnard Life Sciences LLC

Michael E. Hanson
Michael L. Eagle
John Barnard
Eiteljorg Museum of American Indians & Western Art

Other Consumer Services

Ronald W. Dollens
Michael L. Eagle
Third Rock Ventures LLC

Investment Managers

Steven Paul
Mary Lynne Hedley
Mark Levin
American Diabetes Association Research Foundation, Inc.

Ginger Graham
William L. Lister
Marian University

Other Consumer Services

Marvin White
James Cornelius
The Children's Museum of Indianapolis, Inc.

Other Consumer Services

Melissa Barnes
Michael Sherman
Harvard Medical School

Other Consumer Services

Freda Lewis-Hall
William Kaelin
Mind Trust

Miscellaneous Commercial Services

Leigh Pusey
Barton Peterson
Apexian Pharmaceuticals, Inc.

Pharmaceuticals: Major

David A. Broecker
Homer Pearce
John Barnard
Martin F. Haslanger
Avillion LLP

Kurt Wheeler
Anders Gersel Pedersen
Intersect Illinois

Juan Luciano
Douglas Oberhelman
Kovina Therapeutics, Inc.

Susan Mahony
William Ringo

Aktive Beziehungen

Vergangene Beziehungen

Verbindungsstatistiken

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Aktivitäten der verbundenen Unternehmen

Miscellaneous Commercial Services14
Other Consumer Services13
Pharmaceuticals: Major13
Investment Managers5
Medical/Nursing Services2
Biotechnology2
Medical Specialties2
Hospital/Nursing Management1
Investment Trusts/Mutual Funds1
Electric Utilities1

Länder der verbundenen Unternehmen

Vereinigte Staaten91
China3
Vereinigtes Königreich2
Dänemark2
Schweiz1

Unternehmensprofil

Logo Eli Lilly and Company
Eli Lilly and Company ist einer der führenden Pharmakonzerne der Welt. Der Nettoumsatz verteilt sich wie folgt auf die einzelnen Therapiegebiete: - Endokrinologie (65,5%): Produkte zur Behandlung von Osteoporose, Diabetes und Wachstumsstörungen; - Onkologie (19,4%); - Immunologische Erkrankungen (9,8%); - Neurologie (3,3%): hauptsächlich Medikamente zur Behandlung von Depressionen und Schizophrenie; - Sonstige (2%). Der Nettoumsatz verteilt sich geografisch wie folgt: Vereinigte Staaten (67,4%), Europa (15,4%), Japan (4%), China (3,7%) und Sonstige (9,5%).
Beschäftigte
47.000
Sektor
Pharmazeutika
Termine
11.02. - Q4 2025 Ergebnisveröffentlichung (geplant)
Mehr Unternehmensinformationen
  1. Börse
  2. Aktien
  3. 858560 Aktie
  4. Unternehmen Eli Lilly and Company
  5. Verbindungen

Bitte wählen Sie Ihre Ausgabe

Alle länderspezifischen Finanzinformationen

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
Vereinigte Staaten

MarketScreener is also available in this country: United States.

Switch edition
Bei der aktuellen länderspezifischen Edition bleiben